AR007077A1 - Derivados tetrahidroisoquinolina, un procedimiento para su preparacion, una composicion farmaceutica que los contiene, el uso de los mismos parala fabricacion de un medicamento - Google Patents
Derivados tetrahidroisoquinolina, un procedimiento para su preparacion, una composicion farmaceutica que los contiene, el uso de los mismos parala fabricacion de un medicamentoInfo
- Publication number
- AR007077A1 AR007077A1 ARP970101953A ARP970101953A AR007077A1 AR 007077 A1 AR007077 A1 AR 007077A1 AR P970101953 A ARP970101953 A AR P970101953A AR P970101953 A ARP970101953 A AR P970101953A AR 007077 A1 AR007077 A1 AR 007077A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- alkoxy
- group
- optionally substituted
- ring
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 2
- 150000003976 azacycloalkanes Chemical class 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 125000002861 (C1-C4) alkanoyl group Chemical group 0.000 abstract 1
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 abstract 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 102000015554 Dopamine receptor Human genes 0.000 abstract 1
- 108050004812 Dopamine receptor Proteins 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000005422 alkyl sulfonamido group Chemical group 0.000 abstract 1
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000003435 aroyl group Chemical group 0.000 abstract 1
- 125000005533 aryl carboxamido group Chemical group 0.000 abstract 1
- 125000005421 aryl sulfonamido group Chemical group 0.000 abstract 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 abstract 1
- 125000005279 aryl sulfonyloxy group Chemical group 0.000 abstract 1
- -1 arylsulfonylalkyl Chemical group 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000005112 cycloalkylalkoxy group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- RAHZWNYVWXNFOC-UHFFFAOYSA-N sulfur dioxide Inorganic materials O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 abstract 1
- 125000003039 tetrahydroisoquinolinyl group Chemical class C1(NCCC2=CC=CC=C12)* 0.000 abstract 1
- 125000005951 trifluoromethanesulfonyloxy group Chemical group 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
Un derivado tetrahidroisoquinolina, según los compuestos de fórmula (I), en la cual R1 es un sustituyente seleccionado de: un átomo de hidrógeno ohalógeno; un grupo hidroxi, ciano, nitro, trifluormetilo, trifluormetoxi, trifluormetanosulfoniloxi, alquilo C1-4, alcoxi C1-4, arilalcoxi C1-4,alquiltio C1-4, alcoxi C1-4-alquilo C1-4, cicloalquil C3-6-alcoxi C1-4, alcanoilo C1-4, alcoxi C1-4-carbonilo, alquilsulfonilo C1-4, alquilsulfoniloxiC1-4, alquilsulfonil C1-4-alquilo C1-4, arilsulfonilo, arilsulfoniloxi, arilsulfonilalquilo C1-4, alquil C1-4-sulfonamido, alquil C1-4-amido,alquil C1-4-sulfonamidoalquilo C1-4, alquil C1-4-amido-alquilo C1-4, arilsulfonamido, arilcarboxamido, arilsulfonamido-alquilo C1-4,arilcarboxamido-alquilo C1-4, aroilo, aroil-alquilo C1-4, o aril-alcanoilo C1-4; un grupo R3OCO(CH2)p, R3CON(R4)(CH2)p, R3R4NCO(CH2)p o R3R4NSO2(CH2)p donde cada uno deR3 y R4 es independientemente un átomo de hidrógeno o un grupo alquilo C1-4o R3R4 forma parte de un anillo de azacicloalcano C3-6 o (2-oxo)azacicloalcanoC3-6 y p es cero o un número entero de 1 a 4, o un grupo Ar2-Z, en el cual Ar2 es un anillo de fenilo opcionalmente sustituido o un anillo aromáticoheterocíclico de5 a 6 miembros opcionalmente sustituido y Z es un enlace, O, S, o CH2; R2 es un átomo de hidrógeno o un grupo alquilo C1-4; q es 1 o 2; Ary Ar1 es cada uno independientemente un anillo de fenilo opcionalmente sustituido o un anillo heterocíclico aromático de 5 o 6 miembros opcionalmentesustituido; e Y es un enlace, -NHCO-, -CONH-, -CH2-, o -(CH2)mY1(CH2)n-, en el cual Y1 es O, S, SO2, o CO y m y n son cada uno cero o 1, tal que lasuma de m+n es cero o 1; y sus sales, tienen actividad sobre los receptores de la dopamina y son útiles en el tratamiento de psicosis tales como la
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9609888.4A GB9609888D0 (en) | 1996-05-11 | 1996-05-11 | Compounds |
| GBGB9617189.7A GB9617189D0 (en) | 1996-08-16 | 1996-08-16 | Compounds |
| GBGB9704490.3A GB9704490D0 (en) | 1997-03-05 | 1997-03-05 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR007077A1 true AR007077A1 (es) | 1999-10-13 |
Family
ID=27268278
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970101953A AR007077A1 (es) | 1996-05-11 | 1997-05-09 | Derivados tetrahidroisoquinolina, un procedimiento para su preparacion, una composicion farmaceutica que los contiene, el uso de los mismos parala fabricacion de un medicamento |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6046210A (es) |
| EP (1) | EP0917530B1 (es) |
| JP (1) | JP2000510137A (es) |
| KR (1) | KR20000010905A (es) |
| AR (1) | AR007077A1 (es) |
| AT (1) | ATE232850T1 (es) |
| AU (1) | AU2897497A (es) |
| BR (1) | BR9709220A (es) |
| CA (1) | CA2253927A1 (es) |
| CZ (1) | CZ363298A3 (es) |
| DE (1) | DE69719191T2 (es) |
| ES (1) | ES2191838T3 (es) |
| IL (1) | IL126747A0 (es) |
| NO (1) | NO985242L (es) |
| NZ (1) | NZ332477A (es) |
| PL (1) | PL329803A1 (es) |
| TR (1) | TR199802284T2 (es) |
| WO (1) | WO1997043262A1 (es) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69704060T2 (de) * | 1996-08-14 | 2001-08-02 | Smithkline Beecham P.L.C., Brentford | Tetrahydroisochinolinderivate und ihre pharmazeutische anwendung |
| GB9708694D0 (en) * | 1997-04-30 | 1997-06-18 | Smithkline Beecham Plc | Compounds |
| GB9708805D0 (en) * | 1997-05-01 | 1997-06-25 | Smithkline Beecham Plc | Compounds |
| CN1261350A (zh) * | 1997-05-03 | 2000-07-26 | 史密丝克莱恩比彻姆有限公司 | 作为多巴胺d3受体调节剂的四氢异喹啉衍生物 |
| GB9709303D0 (en) * | 1997-05-09 | 1997-06-25 | Smithkline Beecham Plc | Compounds |
| TW450954B (en) * | 1998-05-14 | 2001-08-21 | Pharmacia & Amp Upjohn Company | Phenylsulfonamide-phenylethylamines useful as dopamine receptors |
| GB9810876D0 (en) * | 1998-05-20 | 1998-07-22 | Smithkline Beecham Plc | Compounds |
| GB9812522D0 (en) * | 1998-06-10 | 1998-08-05 | Smithkline Beecham Plc | Compounds |
| GB9821978D0 (en) * | 1998-10-08 | 1998-12-02 | Smithkline Beecham Plc | Compounds |
| GB9821977D0 (en) * | 1998-10-08 | 1998-12-02 | Smithkline Beecham Plc | Compounds |
| BR9914370A (pt) | 1998-10-08 | 2001-11-27 | Smithkline Beecham Plc | Derivados de tetraidrobenzazepina úteis comomoduladores de receptores para a dopamina d3(agentes antipsicóticos) |
| AR022228A1 (es) | 1999-01-12 | 2002-09-04 | Abbott Gmbh & Co Kg | Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para la preparar dicha composicion |
| ES2316777T3 (es) | 2002-02-15 | 2009-04-16 | Glaxo Group Limited | Moduladores de receptores vainilloides. |
| AR040126A1 (es) | 2002-05-29 | 2005-03-16 | Glaxo Group Ltd | Compuesto de fenilsulfonilo, composicion farmaceutica que lo comprende y su uso para la elaboracion de un medicamento |
| US7659400B2 (en) * | 2003-07-31 | 2010-02-09 | Washington University | Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging |
| JP2007500730A (ja) * | 2003-07-31 | 2007-01-18 | ワシントン ユニバーシティ イン セント ルイス | 固形癌の増殖状態を画像化するためのシグマ−２受容体ラジオトレーサー |
| BRPI0511993A (pt) * | 2004-07-20 | 2008-01-22 | Siena Biotech Spa | compostos moduladores de receptores de acetilcolina nicotìnicos alfa7, composições farmacêuticas e usos terapêuticos dos mesmos |
| EP2527337A1 (en) * | 2005-04-14 | 2012-11-28 | Bristol-Myers Squibb Company | Inhibitors of 11-beta hydroxysteroid dehydrogenase type I |
| CL2008000119A1 (es) | 2007-01-16 | 2008-05-16 | Wyeth Corp | Compuestos derivados de pirazol, antagonistas del receptor nicotinico de acetilcolina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como demencia senil, alzheimer y esquizofrenia. |
| US9227944B2 (en) | 2008-10-10 | 2016-01-05 | Institute Of Pharmacology And Toxicology Academy Of Military Science P.L.A. China | Dopamine D3 receptor ligands and preparation and medical uses of the same |
| WO2010040274A1 (zh) | 2008-10-10 | 2010-04-15 | 中国人民解放军军事医学科学院毒物药物研究所 | 新型多巴胺d3受体配体，其制备方法及其医药用途 |
| WO2016034673A1 (en) | 2014-09-03 | 2016-03-10 | Ctxt Pty Ltd | Tetrahydroisoquinoline derived prmt5-inhibitors |
| GB201415573D0 (en) | 2014-09-03 | 2014-10-15 | Cancer Therapeutics Crc Pty Ltd | Compounds |
| US10005792B2 (en) | 2014-09-03 | 2018-06-26 | Ctxt Pty. Ltd. | Aminoindane-, aminotetrahydronaphthalene- and aminobenzocyclobutane-derived PRMT5-inhibitors |
| GB201604030D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
| GB201604031D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
| GB201604022D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
| GB201604027D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
| GB201604029D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
| GB201604020D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
| WO2018021447A1 (ja) | 2016-07-28 | 2018-02-01 | 塩野義製薬株式会社 | ドーパミンｄ３受容体拮抗作用を有する含窒素縮環化合物 |
| TW201938537A (zh) | 2018-01-26 | 2019-10-01 | 日商鹽野義製藥股份有限公司 | 具有多巴胺ｄ３受體拮抗作用的稠環化合物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5294621A (en) * | 1992-10-07 | 1994-03-15 | Ortho Pharmaceutical Corporation | Thieno tetrahydropyridines useful as class III antiarrhythmic agents |
| DE4425146A1 (de) * | 1994-07-15 | 1996-01-18 | Basf Ag | Verwendung heterocyclischer Verbindungen |
-
1997
- 1997-05-06 CA CA002253927A patent/CA2253927A1/en not_active Abandoned
- 1997-05-06 AT AT97923065T patent/ATE232850T1/de not_active IP Right Cessation
- 1997-05-06 KR KR1019980709052A patent/KR20000010905A/ko not_active Withdrawn
- 1997-05-06 PL PL97329803A patent/PL329803A1/xx unknown
- 1997-05-06 JP JP09540515A patent/JP2000510137A/ja not_active Ceased
- 1997-05-06 BR BR9709220A patent/BR9709220A/pt not_active Application Discontinuation
- 1997-05-06 TR TR1998/02284T patent/TR199802284T2/xx unknown
- 1997-05-06 CZ CZ983632A patent/CZ363298A3/cs unknown
- 1997-05-06 AU AU28974/97A patent/AU2897497A/en not_active Abandoned
- 1997-05-06 WO PCT/EP1997/002434 patent/WO1997043262A1/en not_active Ceased
- 1997-05-06 DE DE69719191T patent/DE69719191T2/de not_active Expired - Fee Related
- 1997-05-06 ES ES97923065T patent/ES2191838T3/es not_active Expired - Lifetime
- 1997-05-06 US US09/180,156 patent/US6046210A/en not_active Expired - Fee Related
- 1997-05-06 NZ NZ332477A patent/NZ332477A/xx unknown
- 1997-05-06 IL IL12674797A patent/IL126747A0/xx unknown
- 1997-05-06 EP EP97923065A patent/EP0917530B1/en not_active Expired - Lifetime
- 1997-05-09 AR ARP970101953A patent/AR007077A1/es unknown
-
1998
- 1998-11-10 NO NO985242A patent/NO985242L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US6046210A (en) | 2000-04-04 |
| CZ363298A3 (cs) | 1999-06-16 |
| EP0917530A1 (en) | 1999-05-26 |
| PL329803A1 (en) | 1999-04-12 |
| BR9709220A (pt) | 1999-08-10 |
| IL126747A0 (en) | 1999-08-17 |
| ATE232850T1 (de) | 2003-03-15 |
| WO1997043262A1 (en) | 1997-11-20 |
| EP0917530B1 (en) | 2003-02-19 |
| NO985242L (no) | 1998-12-09 |
| NO985242D0 (no) | 1998-11-10 |
| JP2000510137A (ja) | 2000-08-08 |
| AU2897497A (en) | 1997-12-05 |
| DE69719191D1 (de) | 2003-03-27 |
| KR20000010905A (ko) | 2000-02-25 |
| DE69719191T2 (de) | 2003-11-27 |
| CA2253927A1 (en) | 1997-11-20 |
| ES2191838T3 (es) | 2003-09-16 |
| TR199802284T2 (xx) | 2000-05-22 |
| NZ332477A (en) | 2000-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR007077A1 (es) | Derivados tetrahidroisoquinolina, un procedimiento para su preparacion, una composicion farmaceutica que los contiene, el uso de los mismos parala fabricacion de un medicamento | |
| AR023681A1 (es) | Derivados de tetrahidrobenzazepinas, composiciones farmaceuticas y el uso de los mismos para la manufactura de un medicamento. | |
| AR033306A1 (es) | Compuestos | |
| AR013078A1 (es) | Derivados de tetrahidroisoquinoleina, una sal de los mismos, procedimiento para su preparacion, composicion farmaceutica que los comprende y el uso de losmismos en la preparacion de un medicamento. | |
| AR004219A1 (es) | Nuevos derivados de quinazolina, procedimientos para su preparacion, composiciones que los contienen y su uso en la preparacion de medicamentos,particularmente en el tratamiento de trastornos inflamatorios | |
| AR007440A1 (es) | Compuestos triciclos fenilamino sustituidos y composiciones farmaceuticas de los mismos. | |
| AR034792A1 (es) | Derivados de 1-fenilsulfonil-1,3-dihidro-2h-indol-2-ona, su preparacion y su aplicacion en terapeutica | |
| AR027437A1 (es) | Derivados de purina | |
| ES2173846T3 (es) | Compuestos de biciclocarbonil indol como agentes antiinflamatorios/analgesicos y como inhibidores de cox-2. | |
| ES2100907T3 (es) | Bencimidazoles, medicamentos que contienen estos compuestos y proced imiento para su preparacion. | |
| PT1289955E (pt) | Piperidinas para utilizacao como antagonistas dos receptores da orexina | |
| PA8582801A1 (es) | Nuevos derivados espirotricíclicos y su uso como inhibidores de la fosfodiesterasa | |
| AR011189A1 (es) | 1,4-benzotiazepin-1,1-dioxidos hipolipemiantes, composiciones farmaceuticas, uso de dichos compuestos para fabricar medicamentos y metodos para preparar dichos compuestos y compuestos intermediarios para su preparacion | |
| AR039127A1 (es) | Compuesto de quinolina, procedimiento para su preparacion, composicion farmaceutica que lo comprende y uso del mismo para la fabricacion de un medicamento | |
| AR035153A1 (es) | Derivados de carboxamidas y cetonas de dihidrobenzodioxina | |
| MEP12708A (en) | Derivatives of n-[phenyl (alkylpiperidine-2-yl) methyl]benzamide, preparation method thereof and application of same in therapeutics | |
| AR008291A1 (es) | Derivados de tetrahidroisoquinolina, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y su uso para la preparacionde un medicamento. | |
| CO5271675A1 (es) | Derivados de decahidro-isoquinolinas, proceso para su preparacion, composicion y compuestos farmaceuticos que los contienen | |
| AR009938A1 (es) | Nuevos derivados de arilglicinamida, procedimientos para su preparacion y composiciones farmaceuticas que contienen estos compuestos | |
| AR034174A1 (es) | Compuestos de benzoxazinona, procedimiento para su preparacion, composiciones farmaceuticas que lo comprenden, procedimiento para la preparacion de tales composiciones, y el uso de dichos compuestos o composiciones en la fabricacion de medicamentos | |
| AR007108A1 (es) | Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes. | |
| EA200300044A1 (ru) | Новые замещенные фталиды, способ их получения и содержащие их фармацевтические композиции | |
| AR006261A1 (es) | Antagonistas de bradiquinina heterociclicos, sustituidos con fluoroalquilo fluoroalcoxi, procedimiento para su preparacion y su utilizacion para lapreparacion de un medicamento y dicho medicamento | |
| PE20021018A1 (es) | DERIVADOS DE ß - CARBOLINA | |
| HUP9904210A2 (hu) | Kamptotecin-analógok, alkalmazásuk gyógyszerként és ilyen vegyületeket tartalmazó gyógyászati készítmények |